Sialic acid in cardiovascular diseases

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 1, 2006, Pages 54-61

  Nigam, P K ^a,b   Narain, V S ^a   Kumar, Ajay ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b GSVM MEDICAL COLLEGE   (India)

Author keywords

Cardiovascular diseases; Sialic acid

Indexed keywords

C REACTIVE PROTEIN; GLYCOLIPID; GLYCOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; N ACETYLNEURAMINIC ACID; NEURAMINIC ACID; OLIGOSACCHARIDE; SIALIC ACID; SIALIDASE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; ERYTHROCYTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MORTALITY; NONHUMAN; PATHOGENESIS; RACE DIFFERENCE; REVIEW; STROKE; THROMBOCYTE;

EID: 33644927305     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02913067     Document Type: Review

References (83)

1. Lindberg, G., Eklund, G.A., Gullberg, Bo and Rastam L. (1991). Serum sialic acid concentration and cardiovascular mortality. Br. Med. J. 302, 143-146.
2. Lindbreg, G., Rastam, L., Gullberg, B. and Eklund, G.A. (1992). Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54385 men and women during 20.5 years of follow up. Int. J. Epidemiol. 21, 253-257.
3. Allain, P. Olivier, E., Le Bouil, A., Benoit, C. Geslin, P. and Tadei, A. (1996). Increase of Sialic acid concentration in the plasma of patients with coronary disease. Presse Med. 25, 96-98.
4. Wakabayashi, I., Sakamoto, K., Yoshi moto, S. and Kakishita, E. (1994). Serum sialic acid concentration and atherosclerotic risk factors. J. Atheroscler, Thromb. I, 113-117.
5. Haq. M., Haq, S., Tutt, P. and Crook, M. (1993). Serum total and lipid- associated sialic acid in normal individual's and patient with myocardial infarction and their relationship to acute phase proteins. Ann. Clin. Biochem. 30, 383-386.
6. Crook, M.A., Treloar, A., Haq, M., and Tutt, P. (1994). Serum total sialic acid and acute phase proteins in elderly subjects. Eur. J. Clin. Chem. Clin Biochem. 32, 745-747.
7. Nigam, P.K., Narain, V.S.,Chandra, N., Puri, V.K., Saran, R.K., Dwivedi, S.K. and Hasan, M. (1995). .Serum and platelet sialic acid in acute myocardial infarction. Ind. J. Clin. Biochem. 10, 106-109.
8. Watts, G.F., Crook, M.A., Haq, S. and Mandalia, S. (1995). Serum sialic acid as an indicator of change in coronary artery disease. Metabolism 44, 147-148.
9. Gracheva, E.V., Samovilova, N.N., Golovanova, N.K., Il'inskoya, O.P., Trarak, E.M., Malysher, P.P., Kukharchuk, N.V. and Prokazova, N.V. (2002). Sialyletransferase activity of human plasma and aortic intima is enhanced in otherosclions Biochem. Biophys. Acta. 1586 (1), 123-128.
10. Vaya, A., Falco, C., Reganon, E., Vila, V., Martinez-Sales, V., Corella, D., Contreras, M.T. and Aznar, J. (2004). Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Thromb. Haemostas 91, 354-359.
11. Knuiman, M.W., Watts, G.F. and Divitini, M.L. (2004). Is sialic acid an independent risk factor for cardiovascular disease? A 17-years followup study in Busselton, Western Australia. Ann. Epidemiol. 14, 627-632.
12. Mandic, R., Opper , C., Krappe, J. and Wesmann, W. (2002). Platelet sialic acid as a potential pathogenic factor in coronary disease. Diabetes Res. Clin. Pract. 58, 37.
13. Hedengue, A., Razavian, S.M., Del.-Pino, M., Simon, A. and Levenson, J. (1996). Influence of sialic acid on enythrocyte aggregation in hypercholesterolaemia. Thromb. Haemost. 76, 944-949.
14. Orekhov, A.N., Tertov, V.V., Mukhim, D.N. and Mikhallenko, I.A. (1989). Modification of low density liportotein by desialylation causes lipid accumulation in cultured cells Discovery of desialytated lipoprotein with altered cellular metabolism in the blood of atheroselerotic patients. Boiochem. Biophys. Res. Common. 162, 206-211.
15. Sillanaukee, P., Ponnio, M. and Jaaskelainen, I.P. (1999). Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Invest. 29, 413-425.
16. Taniuchi, K., Chifu, K., Hayastri, N. et al. (1981). A new enzymatic method for the determination of Sialic acid in serum and it application for a marker for acute phase reactants. Kobe J. Med. Sci. 27, 91-102.
17. Petren, S. and Vesterberg, O. (1989). The N-acetylneuraminic acid content of five forms of human tranferrin. Biochim. Biophys. Acta 994, 161-165.
18. Corfield, A.P. Wember, M. Schauer, R. and Rott, R. (1982). The specificity of Viral sialidases. The use of oligosaccharide susbtrate to probe enzymic characteristics and strain specific differences. Eur. J. Biochem. 124, 521-526.
19. Haverkamp, J., Schauer, R. and Wember, M. (1976). Neuraminic acid derivatrives newly discovered in humans. Hoppe Seyler's Z. Physiol. Chem. 357, 1699-1705.
20. Schauer, R. (1982). Chemistry, metabolism and biological functions of sialic acids. Adv. Carbohyd. Chem. Biochem. 40, 131-234.
21. Rosenberg, A. (1995). Biology of the "Sialic Acids" Plenum, New York.
22. Schauer, R. and Kamerling, J.P. (1997). Chemistry, biochemistry and biology of sialic acids. In "Ghycoproteins" J. Montreuil, H. Schachter and J.F.G. Vliegenthart. Eds.
23. Schauer, R., Kelm,. S., Reuter, G., Roggentin, P. and Shaw, L. (1995). Biochemistry and role of sialic acids. In "Biology of Silaic acids" (A Rosenberg, Ed.). p 7-67 , Plenum, New York .
24. Varki, A. (1992). Diversity in the sialic acids. Glycobiology 2, 25-40.
25. Kelm, S. and Schauer, R. (1997). Sialic acids in molecular and cellular interaction. Int. Rev. Cytol. 175, 137-240.
26. Rastam, L., Lindberg, G., Folsom, A.R., Burke, G.L., Nilsson- Ehle, P. and Lundblad, A. (1996). Association between serum sialic acid concentration and carotid atherosclerosis measured by B-Mode untrasound. Int. J. Epidemiol. 25, 1953-1958.
27. Pyoralla, K., Laasko, M. and Uusitupa, M. (1987). Diabetes. and atherosclerosis : an epidemiologic view. Diabetes Metab. Rev. 3, 463-524.
28. Pick up, J.C. and Mattock, M.B. (2003). Activation of the innate immune system as a predictor of cardiovascular mortality in type 2 diabetes mellitus. Diabet. Med. 20, 723-726.
29. Crook, M. and Tutt, P. (1992). Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Fredrickson's II B phenotype. Clin. Sci. 83, 593-595.
30. Wakabayashi, I,. Sakamoto, K., Yoshimoto, S. and Masui, H.P. (1992). Relation of serum sialic acid to lipid concentration. Br. Med. J. 305, 562-563.
31. Crook , M., Lumb, P., Andrews, V. and Swaminathan, R. (1998). Serum total sialic acid , a reputed cardiovascular risk factor and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. Clin. Sci. 95, 53-57.
32. Masuda, H., Wakabayashi, R. and Wakabayashi, I. (1998). Serum sialic acid and ankle versus brachial arterial pressure ratio in NIDDM. Scand. J. Clin. Lab. Invest. 58, 433-439.
33. Zahedi, R.G., Summers, L.K., Lumb, P. ,Chik, G and Crook, M.A. (2001). The response of serum sialic acid and other acute phase reactants to an oral fat lead in healthy humans. Eur. J. Intern. Med. 12, 510-514.
34. Wakabayashi, I. and Masuda, H. (2002). Relation of serum sialic acid to blood coagulation activity in type 2 diabetes. Blood Coagul. Fibrinolysis 13, 691-696.
35. Gokmen, S.S., Kilicli., G., Ozcelik, F., Ture, M. and Gulen S. (2002). Association between serum total and lipid- bound sialic acid concentration and the severity of coronary atherosclerosis. J. Lab. Clin. Med. 140, 110-118.
36. Salomone, O.A. Croon, J.R., Hossein- Niam., Holt, D. and Kaski, J.C. (1998). Serum sialic acid concentration is not associated with the extent or severity of coronary disease in patients with stable angina pectoris. J. Lab. Clin. Med. 140, 110-118.
37. Wu, E.B., Lumb, P., Chambers, J.B. and Crook, M.A. (1999). Plasma sialic acid and coronary artery atherosclerosis load in patients with stable chest pain. Atherosclerosis 145, 261-266.
38. Flynn, M.D., Corrall, R.J.M., Waters, P.J. and Pennock, C.A. (1991). Sialic acid and cardiovascular mortality. Br. Med. J. 302, 533-534.
39. Morell, A.G., Gregoriadis, G., Scheinberg, I.H., Hickman, J. and Ashwell, G. (1971). The role of glycoproteins in the circulation . J. Biol. Chem. 246, 1461-1467.
40. Baumann, H. and Gauldie, J. (1994). The acute phase response. Immunol. Today 15, 74-80.
41. Lindberg, G., Rastom, L., Nilsson-Ehle, P., Lundblad, A., Ramstam, J., Folsom, A.R. and Bruke, G.L. (1999). Serum sialic acid and asialoglycoproteins in asymptomatic carotid artery atherosclerosis, ARIC Investigators, Atherosclerosis Risk in Communities. Atherosclerosis 146, 65-69.
42. Gokmen, S.S. , Kilicli, G., Ozcelik, F. and Gulen S. (2000). Serum total and lipid bound sialic acid levels following acute myocardial infarction. Clin. Chem. Lab. Med. 38, 1249-1255.
43. Berkan, O. and Sagban. M. (2002). Sialic acid or Troponin T to detect perioperative myocardial damage in patients undergoing elective coronary artery bypass grafting. Cir. J. 66, 1019-1023.
44. Orekhov, A.N., Tertov, V.V., Murhin, D.N. and Kabakov, A,.E. (1989). Modified (desialytated) low density liporotein and auto antibodies against lipoprotein circulating in the blood of atherosclerotic patients cause atherosclerotic mnifestation in aortic cell culture . In : Descovich, G.C., editor, Atherosclerosis and cardiovascular disease. Bologna Editrice composition.
45. Orekhov, AN. Tertov. V.V. and Mukhin, D.N. (1991). Desialylated low density lipoproteins-naturally occurring lipoprotein with atherogenic potency. Atherosclerosis 86, 153-161.
46. Tertov, V.V., Sobenin, I.A. Gabbasov, Z.A., et al. (1992). Multhiple- modified desialylated low density lipoproteins that cause intracellular lipid accumulation, Isolation, fractionation and Characterization . Lab . Invest. 67, 665-675.
47. Tertov, V.V., Kaplun, V.V., Sobenin, Z.A. and Orekhov, A.N.(1998). Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification . Atherosclerosis 138, 183-195.
48. Kruth, H.S. (1997). The fate of lipoprotein Cholesterol entering the arterial wall. Curr. Opin. Lipidol. 8, 246-252.
49. Sprague, E.A., Moser, M., Edwards, E.H. and Schwartz, C.J. (1998). Stimulation of receptor-mediated low density lipoproteins endocytosis in neuraminidase- treated cultured bovine aortic endothelial cells. J. Cell Physiol. 137, 251-262.
50. Malmendier, C.L., Delcroix, C. and Fontaine, M. (1980). Effect of sialic acid removal on human low density lipoprotein catabosism in vivo. Atherosclerosis 37, 277-284.
51. Filipovic, I. and Buddecke, E. (1979). Desialized low - density lipoprotein regulates cholesterol metabolism in receptor- deficient fibroblastz. Eur. J. Biochem. 101, 119-122.
52. Melajarvi, N., Gylling, H. and Miettinen, T.A. (1996). Sialic acid and the metabolism of low-density lipoproteins. J. Lipid Res. 37, 1625-1631.
53. Chappey, B., Myara, I., Giral, P., Kerharo, G., Plainfosse, M.C. Levenson, J., Simon, A. and Moati. N. (1995). Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA group. Arterioscler. Thromb. Vasc. Biob. 15, 334-339.
54. Chappey , B.,Beyssen, B., Foos, E. , Ledru, F., Guermonprez , J.L., Gaux, J.C. and Myara, I. (1998). Sialic acid content of LDL in coronary artery disease: no evidence of of desialylation in subjects with coronary stenosis and increased level in subjects with extensive atherosclerosis and acute myocardial infarction : relation between desialylation and in vitro peroxidation. Arterioscler. Thromb. Vasc. Biol. 18, 876-883.
55. Crook M., Kerai, P., Andrews, V., Lumb, P. and Swaminatham, R. (1998). Serum total sialic acid, a reputed cardiovascular risk factor, is elevated in South Asian men compared to European men. Ann. Clin. Biochem. 35, 242-244.
56. Lindberg, G., Iso, H., Rastom, L., Lundblad, A. and Folsom, A.R. (1997). Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA, Int. J. Epidemiol. 26, 58-63.
57. Seaman, G.V.F. and Vassar, P.S. (1966). Changes in electrokinetic properties of platelets during their aggregation. Arch. Biochem. Biophys. 117, 10-17.
58. Seaman, G.V.F. (1967). Surface potential and platelet aggregation. In: Platelets, their role in heamostasis and thrombosis. Ed. Brinkhous, K.M., Wright, I.S., Soulier, J.P., Robers, H.R. and Hinnoms, S. p. 53-68.
59. Grothum, K.A. (1969). Platelet surface charge and aggregation effects of polyelectrohytes. Thrombos. Diathes Haemorrh. 21, 450-462.
60. Hampton. J.R. and Mitchell, J.R.A. (1969). Modification of the electrokinetic response by blood platelets to aggregating agents. Nature 210, 1000-1003.
61. Isohisa, I., Jung., S. M., Motomiya, T., et al. (1981). Relations among electrophoretic mobility, sialic acid and platelet aggregability and its interpretation. Ketsuekito Myakkan. 12, 564-567.
62. Yamazaki, H., Jng, S.M., Tanoue, K., et al. (1981). Surface negative charge, membrane glyco proteins and functions of platelets. Ketsuekito. Myakkam. 12, 520-531.
63. Jung, S.M., Kinoshita, K., Tanoue, K., Isohisa, I. and Yamazaki, H. (1982). Role of surface negative charge in platelet function related to the hyperactive state in estrogen treated prostatic carcinoma. Thromb. Haemostasis 43, 203-209.
64. Tanoue, K., Jung., S.M., Yamamoto, N. and Yamazaki, H. (1984). The role of surface negative charge on platelets function. Electrophor. 83. Adv. Methods. Biochem. Clin. Appl. Proc. Int. Conf. p. 333-340.
65. Choi, S.I., Simone, J.V. and Journey, L.J. (1982). Neuramindase- induced thrombo-cytopenia in rats. Br. J. Haematol. 22, 93-99.
66. Grottum, K.A. and solumn, N.O. (1969). Congenital thrombocytopenia with giant platelets: A defect in platelet membrane. Br. J. Haematol. 16, 275-290.
67. Steele P.P., Weily, H.S., Davies, H. and Genton, E. (1973). Platelet function studies in coronary artery disease. Circulation 48, 1194-1200.
68. Steele, P., Rainwater, J. and Vogel. R. (1978). Abnormal platelet survival time in men with myocardial infarction and normal coronary arteriogram. Am. J. Cardiol. 41, 60-61.
69. Hanson, V., Landarv, S., Flasher, M., Wax, S. and Webb, W. (1980). Sialic acid- depleted red cells following myocardial infarction. Am. Heart J. 99, 483-486.
70. Goswmi, K. and Koner, B. (2002). Level of sialic acid residues in platelet proteins in diabetes, aging and Hodgkin's lymphoma: a potential role of Free radicals in desialylation. Biochem. Biophys. Res. Commun. 297, 502.
71. Aminoff, D., Bell, W.C., Fulton, I. and Ingebrigtsen, N. (1976). Effects of sialidase on the viability of erythrocytes in circulation. Am. J. Haematol. 1, 419-432.
72. Yachin, S. and Gardner, F.H. (1961). Measurment of human erythrocyte neuraminic acid : relationship to haemlysis and red blood cell virus interaction. Br. J. Haematol. 7, 464- 475.
73. Cohen, N.S., Ekholm, J.E., Luthra, M.G. and Hanahan, D.J. (1976). Biochemical characterization of density separated human erythrocytes. Biochimica et Biophysica Acta 419, 229-242.
74. Gattengno, L., Perret, G., Fabia, F. and Cornillot, P. (1981). Decrease of Cabohydrate in membrane glycoproteins during human erythrocyte aging in vivo. Mechansims of aging and development 16, 205-219.
75. Lewis, S.M. (1962). Red cell abnormalities and haemolysis in aplastic anaemia. Br. J. Haematol. 8, 322-334.
76. Janick, J. and Schauer, R. (1974). Sialic acid-A determinant of the life-time of rabbit erythrocytes. Hoppe-Seyler's Z. Physiol. Chem. 355, 395-400.
77. Janick, J., Schauer, R. and Streicher , H.J. (1975). Influence of membrane- bound N-acetylneuraminic acid on the survival of erythrocytes in man. Hoppe- Seyler's Z. Physiol. Chem. 356, 1329-1331.
78. Janick, J.M., Schauer, R., Andres, K.H. and Von During, M. (1978). Sequestration of neuraminidase-treated erythrocytes- studies on its topographic, morphologic and immumologic aspects. Cell Tissue Res. 186, 209-226.
79. Gottschalk, A. (1972). Ghycoproteins . Essex: Elsevia Science Publishers, p 381.
80. Hedengue, A.L., Del-Pino, M., Simon, A. and Levenson, J. (1998). Erythrocyte disaggregation shear stress, sialic acid and cell aging in humans. Hypertension 32, 324-330.
81. Resniszky, P.,Yaari, A. and Danon, D. (1972). Biophysical characteristics of erythrocytes during myocardial infarction and venous thrombosis. Thromb. Diathes Hemorrh. 28, 415-418.
82. Hanson, V.A. Shettigar, V.R. Loungani, R.R. and Nadijcka, M.D. (1987). Plasma sialidase activity in acute myocardial infarction. Am. Heart J. 114, 59-63.
83. Venerando, B. , Fiorilli, A. Croci, G., Tringali, C., Goi, G. Mazzanti, L. Lombardo, A. and Tettamontic, G. (2002). Acute and neutral sialidse in the erythrocyte membrane of type 2 diabetes patients. Blood 99, 1064-1070.